Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| IDEAYA Biosciences, Inc.(IDYA) | 3,000,000 | 3,500,000 | +500,000 | $77.10M | $57.33M | 10.19% | -$19.77M |
| Revolution Medicines, Inc.(RVMD) | 1,450,000 | 1,600,000 | +150,000 | $63.42M | $56.58M | 10.06% | -$6.85M |
| Akero Therapeutics Inc | 800,000 | 1,200,000 | +400,000 | $22.26M | $48.58M | 8.64% | +$26.32M |
| Janux Therapeutics, Inc.(JANX) | 1,250,000 | 1,650,000 | +400,000 | $66.92M | $44.55M | 7.92% | -$22.38M |
| Nuvalent Inc | 0 | 500,000 | +500,000 | $0 | $35.46M | 6.30% | +$35.46M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 0 | 1,700,000 | +1,700,000 | $0 | $26.13M | 4.64% | +$26.13M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 650,000 | +650,000 | $0 | $21.81M | 3.88% | +$21.81M |
| Keros Therapeutics, Inc.(KROS) | 0 | 2,000,000 | +2,000,000 | $0 | $20.38M | 3.62% | +$20.38M |
| Disc Medicine, Inc.(IRON) | 200,000 | 394,342 | +194,342 | $12.68M | $19.58M | 3.48% | +$6.90M |
| BioNTech SEADS(BNTX) | 300,000 | 200,000 | -100,000 | $34.19M | $18.21M | 3.24% | -$15.97M |
| 89bio Inc | 0 | 2,500,000 | +2,500,000 | $0 | $18.18M | 3.23% | +$18.18M |
| Soleno Therapeutics Inc | 350,000 | 250,000 | -100,000 | $15.73M | $17.86M | 3.18% | +$2.13M |
| Erasca, Inc.(ERAS) | 12,500,000 | 13,000,000 | +500,000 | $31.38M | $17.81M | 3.17% | -$13.56M |
| Ocular Therapeutix, Inc.(OCUL) | 3,500,000 | 2,300,000 | -1,200,000 | $29.89M | $16.86M | 3.00% | -$13.03M |
| Design Therapeutics, Inc.(DSGN) | 4,217,627 | 4,217,627 | 0 | $26.02M | $16.28M | 2.89% | -$9.74M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 350,000 | +350,000 | $0 | $13.67M | 2.43% | +$13.67M |
| Geron Corporation(GERN) | 2,000,000 | 8,000,000 | +6,000,000 | $7.08M | $12.72M | 2.26% | +$5.64M |
| Olema Oncology, Inc.(OLMA) | 3,208,875 | 3,208,875 | 0 | $18.71M | $12.07M | 2.14% | -$6.64M |
| Crinetics Pharmaceuticals In | 0 | 350,000 | +350,000 | $0 | $11.74M | 2.09% | +$11.74M |
| Avidity Biosciences Inc | 0 | 350,000 | +350,000 | $0 | $10.33M | 1.84% | +$10.33M |
| Maze Therapeutics, Inc.(MAZE) | 0 | 936,914 | +936,914 | $0 | $10.32M | 1.83% | +$10.32M |
| Annexon, Inc.(ANNX) | 2,550,000 | 4,000,000 | +1,450,000 | $13.08M | $7.72M | 1.37% | -$5.36M |
| Structure Therapeutics IncADS | 700,000 | 425,000 | -275,000 | $18.98M | $7.36M | 1.31% | -$11.63M |
| COMPASS Pathways plcADS(CMPS) | 0 | 2,000,000 | +2,000,000 | $0 | $5.72M | 1.02% | +$5.72M |
| Dyne Therapeutics, Inc.(DYN) | 450,000 | 500,000 | +50,000 | $10.60M | $5.23M | 0.93% | -$5.37M |
| Enliven Therapeutics Inc | 140,000 | 240,000 | +100,000 | $3.15M | $4.72M | 0.84% | +$1.57M |
| Immunovant, Inc.(IMVT) | 300,000 | 275,000 | -25,000 | $7.43M | $4.70M | 0.84% | -$2.73M |
| Aerovate Therapeutics Inc | 1,400,000 | 1,400,000 | 0 | $3.71M | $3.51M | 0.62% | -$196.0K |
| Aclaris Therapeutics, Inc.(ACRS) | 2,222,222 | 2,222,222 | 0 | $5.51M | $3.40M | 0.60% | -$2.11M |
| Unicycive Therapeutics Inc | 5,078,927 | 5,078,927 | 0 | $4.03M | $2.92M | 0.52% | -$1.11M |
| Trevi Therapeutics, Inc.(TRVI) | 1,250,000 | 424,715 | -825,285 | $5.15M | $2.67M | 0.47% | -$2.48M |
| Astria Therapeutics Inc | 500,000 | 500,000 | 0 | $4.47M | $2.67M | 0.47% | -$1.80M |
| Rapport Therapeutics, Inc.(RAPP) | 208,910 | 208,910 | 0 | $3.71M | $2.10M | 0.37% | -$1.61M |
| Glycomimetics Inc | 5,400,000 | 5,400,000 | 0 | $1.34M | $1.13M | 0.20% | -$210.6K |
| Septerna, Inc.(SEPN) | 134,202 | 134,202 | 0 | $3.07M | $777.0K | 0.14% | -$2.30M |
| Allakos Inc | 2,900,000 | 2,900,000 | 0 | $3.51M | $660.0K | 0.12% | -$2.85M |
| Artiva Biotherapeutics, Inc.(ARTV) | 145,089 | 145,089 | 0 | $1.46M | $435.3K | 0.08% | -$1.03M |
| Solid Biosciences Inc | 0 | 100,000 | +100,000 | $0 | $370.0K | 0.07% | +$370.0K |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 66,666 | 66,666 | 0 | $15.3K | $15.9K | 0.00% | +$587 |
| Alkermes plcSHS(ALKS) | 500,000 | 0 | -500,000 | $14.38M | $0 | — | -$14.38M |
| Apellis Pharmaceuticals Inc COM | 500,000 | 0 | -500,000 | $15.96M | $0 | — | -$15.96M |
| Apogee Therapeutics Inc | 300,000 | 0 | -300,000 | $13.59M | $0 | — | -$13.59M |
| Arvinas, Inc.(ARVN) | 700,000 | 0 | -700,000 | $13.42M | $0 | — | -$13.42M |
| Atyr Pharma Inc | 1,000,000 | 0 | -1,000,000 | $3.62M | $0 | — | -$3.62M |
| Blueprint Medicines Corp | 200,000 | 0 | -200,000 | $17.44M | $0 | — | -$17.44M |
| Bright Minds Biosciences Inc.(DRUG) | 245,000 | 0 | -245,000 | $8.82M | $0 | — | -$8.82M |
| Cytokinetics, Incorporated(CYTK) | 900,000 | 0 | -900,000 | $42.34M | $0 | — | -$42.34M |
| Edgewise Therapeutics, Inc.(EWTX) | 400,000 | 0 | -400,000 | $10.68M | $0 | — | -$10.68M |
| Insmed Incorporated(INSM) | 450,000 | 0 | -450,000 | $31.07M | $0 | — | -$31.07M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 175,000 | 0 | -175,000 | $21.55M | $0 | — | -$21.55M |
| Merus N V | 750,000 | 0 | -750,000 | $31.54M | $0 | — | -$31.54M |
| Neurocrine Biosciences, Inc.(NBIX) | 200,000 | 0 | -200,000 | $27.30M | $0 | — | -$27.30M |
| Pliant Therapeutics, Inc.(PLRX) | 750,000 | 0 | -750,000 | $9.88M | $0 | — | -$9.88M |
| Spyre Therapeutics, Inc.(SYRE) | 500,000 | 0 | -500,000 | $11.64M | $0 | — | -$11.64M |
| Travere Therapeutics, Inc.(TVTX) | 1,000,000 | 0 | -1,000,000 | $17.42M | $0 | — | -$17.42M |
| Vaxcyte, Inc.(PCVX) | 300,000 | 0 | -300,000 | $24.56M | $0 | — | -$24.56M |
| Vera Therapeutics, Inc.CL A(VERA) | 875,000 | 0 | -875,000 | $37.00M | $0 | — | -$37.00M |
| Y-Mabs Therapeutics Inc | 1,000,000 | 0 | -1,000,000 | $7.83M | $0 | — | -$7.83M |